Skip to content

PharMatheve

Active Private limited companyfounded 2023active for 2 yearsBurgstraat 52, 2440 GeelKBO/BCE: BE 1003.153.313

Lifetime

3 annual accounts with figures on one time axis
peak of €62,851 in 2025
€62,851▲ 4.8%
lowest -€1,984 in 2023
€48,137▲ 1.4%
peak of €93,769 in 2025
€93,769▲ 105%
€5,169▲ 70.3%
Board1 name since 2023
1 director
Documentsfilings and deeds
12-05-202680 days before the deadline
2025micro format
Equity from €45,632 to €93,769Debts from €3,035 to €5,169Cash from €36,620 to €65,395

Key points

from the 2025 annual accounts

Turnover

≈ €130,000 estimated

The micro format states no turnover.

Position in the sector

94.8%

Higher solvency than 93% of companies in head offices and management consultancy. Sector median 55.5% · 41,270 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as PharMatheve has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for PharMatheve. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 12-12-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1003153313
Incorporation Founding capital of €1,000, 100 shares · Founded by · appointed as director · published on 12-12-2023 · Gazette deed
First establishment Rijn 134, Geel
All 9 events

Comparable companies

same main activity, similar in size and age
Company
PharMatheve Geel €98,938 €62,851 94.8% -
ANS Consulting Geel €92,548 €65,806 27.3% -
Mercury Trade Brasschaat €104,244 €63,244 81.0% -
GP Management & Consulting Antwerp €98,794 €59,396 71.0% -
GERA Consulting Antwerp €93,914 €60,002 76.0% -
SPCON Rijkevorsel €90,979 €65,437 78.8% -
Global Bulk Surveys Wuustwezel €103,532 €61,960 78.8% -

These companies have the same main activity as PharMatheve: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €91,000 and €104,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 08-12-2023Normal situation
Activity
Business and other management consultancyNACE 70200and 4 others
Establishment unit
2.353.234.5492440 Geel, since 08-12-2023
Financial year end
31 December
Peppol
Reachable since 01-06-2026
Company details

Annual accounts 2025

€98,938▲ 103%
Filing
Filed on 12-05-2026, 80 days before the end of the filing period
Financials

Insights on PharMatheve

PharMatheve files the micro format. That format states no turnover. The gross margin rose from -€1,711 in 2023 to €62,851 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PharMatheve

What is the company number of PharMatheve?
The company number of PharMatheve is 1003.153.313. The VAT number is the same number with BE in front: BE 1003.153.313.
Where is PharMatheve based?
The registered office is at Burgstraat 52, 2440 Geel.Company details
What does PharMatheve do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of PharMatheve?
PharMatheve is a private limited company (BV).
When was PharMatheve founded?
PharMatheve was founded on 08-12-2023.
Is PharMatheve still active?
Yes, PharMatheve is an active enterprise in the KBO register.
What is the turnover of PharMatheve?
The turnover in financial year 2025 is ≈ €130,000. This figure is estimated from the gross margin of €62,851 and 139 comparable companies (NACE 70200). It probably lies between €95,000 and €170,000.Financials
Is PharMatheve profitable?
In financial year 2025, PharMatheve made a profit of €48,137.
Where can I find the annual accounts of PharMatheve?
PharMatheve filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PharMatheve due?
PharMatheve must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.